Activation of type 4 metabotropic glutamate receptor promotes cell apoptosis and inhibits proliferation in bladder cancer

Journal of Cellular Physiology
Zhichao ZhangYong Liu

Abstract

Bladder cancer, the second most common genitourinary malignancy, severely endangers the human health. Rising evidence suggests that metabotropic glutamate receptors (mGluRs) are involve in tumor progression. In this study, we observed that metabotropic glutamate receptor 4 (mGluR4) was functionally expressed in normal and cancerous bladder cells and its expression was positively correlated with high bladder cancer grading. We further confirmed that the activation of mGluR4 by VU0155041, an mGluR4-specific agonist, decreased cyclic adenosine monophosphate (cAMP) concentration and cell viability, promoted apoptosis and inhibited proliferation in bladder cancer cells, whereas MSOP (group III mGluR antagonist) or mGluR4 knockdown eliminated the effects of mGluR4 activity. Western blotting revealed the decreased cyclin D1 expression, increased procaspase-8/9/3 cleavage, and unbalanced Bcl-2/Bax expression in bladder cancer cell lines after mGluR4 activation, and likewise MSOP and mGluR4 knockdown abrogated the actions of mGluR4 activity. In vivo study showed that mGluR4 activation significantly inhibited tumor growth of bladder cancer via suppressing proliferation and promoting apoptosis. Furthermore, upregulation of phosphatase and...Continue Reading

References

Feb 7, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J P SteinD G Skinner
May 18, 2001·Nature·P Blume-Jensen, T Hunter
Jul 27, 2002·The Lancet Oncology·Markus Bredel, Josef Zentner
Aug 16, 2003·Molecular Pharmacology·Julie A O'BrienDavid L Williams
Jun 26, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Byong Chul YooJae-Gahb Park
Nov 19, 2004·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·A M CanudasD Melchiorri
May 4, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Hee Jin ChangJae-Gahb Park
Aug 11, 2006·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Luisa IacovelliFerdinando Nicoletti
Oct 21, 2006·American Journal of Physiology. Gastrointestinal and Liver Physiology·Richard L YoungL Ashley Blackshaw
Apr 17, 2007·Trends in Pharmacological Sciences·Ferdinando NicolettiDaniela Melchiorri
May 12, 2007·Brain Research·Inmaculada IglesiasMairena Martín
Jun 15, 2007·Toxicologic Pathology·Susan Elmore
Jul 5, 2007·The Journal of Pharmacology and Experimental Therapeutics·Gentaroh SuzukiHisashi Ohta
Dec 27, 2008·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Kimberly R ByrnesAlan I Faden
Jul 25, 2009·Nature Reviews. Cancer·Jeffrey A Engelman
Jul 30, 2009·Expert Opinion on Therapeutic Targets·Mehtap Cakir, Ashley B Grossman
Jan 9, 2010·Annual Review of Pharmacology and Toxicology·Colleen M Niswender, P Jeffrey Conn
Jan 5, 2011·Nature Reviews. Drug Discovery·Rosamaria Lappano, Marcello Maggiolini
May 17, 2013·Journal of Proteome Research·Kelly H TeluAmir Mortazavi
Jan 21, 2014·Cell Reports·Filip JankuRazelle Kurzrock
Mar 13, 2014·The Journal of Comparative Neurology·Lindsey A WyattHans S Keirstead
Sep 7, 2016·Cancer Cell·Mansoor AhmedMartin A Schwartz

❮ Previous
Next ❯

Citations

Jun 19, 2019·Current Neuropharmacology·Serena BoccellaEnza Palazzo
Sep 19, 2019·Cancer Discovery·Maya KansaraDavid M Thomas
Dec 11, 2021·Science Advances·Zhuoya WanSong Li

❮ Previous
Next ❯

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.